Charles Schwab Investment Management Inc Precigen, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,222,850 shares of PGEN stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,222,850
Previous 1,095,383
11.64%
Holding current value
$1.03 Million
Previous $1.73 Million
32.89%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PGEN
# of Institutions
143Shares Held
159MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$70.1 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$15.1 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$9.13 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$7 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $175M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...